Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Tevagrastim"'
Autor:
Funda Ceran, Mesude Falay, Gülsüm Özet, Merve Pamukçuoğlu, Ahmet Kursad Gunes, Simten Dağdaş, Mehmet Ali Ucar
Publikováno v:
Acta Oncologica Turcica. 54:224-232
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::add65ff647aa3ba9719b1b8760f1daec
https://doi.org/10.5505/aot.2021.45467
https://doi.org/10.5505/aot.2021.45467
Autor:
Patrick Liu, Nicole Lang, Ashutosh Pathak, Ruth Pettengell, Udo Mueller, Henry C. Fung, Andreas Lammerich, Ingo Diel, Anton Buchner, Camille N. Abboud, Hartmut Link
Publikováno v:
Supportive Care in Cancer. 27:2569-2577
Recombinant granulocyte colony-stimulating factors (rG-CSFs), such as filgrastim, are administered to prevent complications in patients receiving chemotherapy. In Europe, a biosimilar to filgrastim, tevagrastim/ratiograstim/biograstim, was approved i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbdf118694944a2cc8669fb57636b6b7
https://doi.org/10.1007/s00520-018-4522-5
https://doi.org/10.1007/s00520-018-4522-5
Autor:
P. Gascon
Publikováno v:
Oncologie. 13:213-217
Biopharmaceuticals were copies of endogenous human proteins developed in the mid-nineties that were characterized by complex three-dimensional, high-molecularweight compounds. What made them unique was that contrary to classical chemotherapeutical dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ce8cf2747ec22fbcfe64f60c873e709
https://doi.org/10.1007/s10269-011-2014-z
https://doi.org/10.1007/s10269-011-2014-z
Publikováno v:
Journal of Clinical Oncology. 32:e17540-e17540
e17540 Background: Medical products registered in the European Union (EU) are subject to Periodic Safety Update Reports (PSURs), which provide comprehensive worldwide safety data assessments and benefit-risk analyses. Methods: The present PSUR for tb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c04281cedb0231133ce4d91011ae032
https://doi.org/10.1200/jco.2014.32.15_suppl.e17540
https://doi.org/10.1200/jco.2014.32.15_suppl.e17540
Autor:
Avichai Shimoni, Rina Sareli, Yulia Volchek, Nira Bloom-Varda, Ivetta Danylesko, Arnon Nagler, Ronit Yerushalmi, Noga Shem-Tov
Publikováno v:
Blood. 122:3275-3275
Introduction Human recombinant G-CSF Filgrastim (Neupogen) has been widely used for the mobilization of CD34+ hematopoietic stem cells (HSC) from healthy donors. The experience with biosimilar G-CSF agents is limited and the only publication, to our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c93a4e96c6b0a9ef2d4f12bc118150a
https://doi.org/10.1182/blood.v122.21.3275.3275
https://doi.org/10.1182/blood.v122.21.3275.3275
Publikováno v:
Biosimilars. :55
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82218be458f990adc2648dac056c35c1
https://doi.org/10.2147/bs.s27712
https://doi.org/10.2147/bs.s27712
Publikováno v:
European Journal of Hospital Pharmacy. 20:A73.1-A73
Background Biosimilars are follow-on versions of peptide biological drugs, and differences in manufacturing and formulation can result in variations in physicochemical and clinical profiles. The European Medicines Agency (EMA) has set stringent stand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9e14d029c8dc3107c36c03e5dc6f04f
https://doi.org/10.1136/ejhpharm-2013-000276.203
https://doi.org/10.1136/ejhpharm-2013-000276.203
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pere Gascón
Publikováno v:
Targeted Oncology
Biopharmaceuticals were copies of endogenous human proteins developed in the mid-1990s that were characterized by complex three-dimensional, high-molecular weight compounds. What made them unique was that contrary to classical chemotherapeutical drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3346259addfebcd967a567a3956b86e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.